Alzprotect
About:
It is a biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.
Website: http://www.alzprotect.com
Top Investors: Michael J. Fox Foundation, Finorpa, Eurasante, Nord France Amorcage, Finovam Gestion
Description:
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).
Total Funding Amount:
$20.2M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Street, Maryland, United States
Founded Date:
2007-01-01
Contact Email:
contact(AT)alzprotect.com
Founders:
Philippe Verwaerde
Number of Employees:
11-50
Last Funding Date:
2022-06-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai